on 14 Nov 2024
Last Applicant/ Owned by
1 WEST FIRST AVENUE
CONSHOHOCKEN
PA
19428
Serial Number
97765170 filed on 23rd Jan 2023
Registration Number
N/A
Correspondent Address
Anita B. Polott
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Medical analysis services, namely, medical diagnostic testing, monitoring and reporting in the field of human disease treatment; providing medical information being a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices being the specific diagnosis, line of therapy, stage of Read More
Medical analysis services, namely, medical diagnostic testing, monitoring and reporting in the field of human disease treatment; providing medical information being a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices being the specific diagnosis, line of therapy, stage of disease and regimen information; providing clinical and home health care services, namely, providing medical and healthcare information relating to therapeutic properties of pharmaceuticals; providing medical counseling and healthcare counseling being health counseling to patients in the field of administration of medications; providing medical clinic and health clinic services; home health care services; providing medical care information being medical information; Health care services, namely, providing wellness programs for disease treatment and management featuring patient-centered incentives for compliance with physician-directed educational, medication therapy, and home care programs; providing medical, health and veterinary information services for the pharmaceutical and medical sectors; providing medical information services in the field of diagnostic, prophylactic and therapeutic properties of pharmaceuticals for the pharmaceutical and medical sectors; providing medical and health counseling and pharmaceutical advice services related to workplace and personnel health; healthcare services; providing medical and healthcare information on medical substances; medical and healthcare consulting being consultancy services relating to medical care and health care in the field of analyzing and reporting of discussions about human disease treatment; medical services being administration and management of sophisticated pharmaceutical therapies; providing medical information, health information, veterinary information, pharmaceutical advice and biotechnical information being healthcare information via a website; remote healthcare and telemedicine services being healthcare services provided via telecommunication in the nature of remote monitoring of data indicative of the health or condition of a patient for medical treatment purposes; remote healthcare and telemedicine services being providing patients with health information relating to their medical condition; beauty consultancy and health care consulting services; providing nursing services to others on behalf of pharmaceutical and biotechnology companies; providing health and nutrition information in the field of animal management; medical consulting, healthcare consulting, and veterinary consulting services in the field of animal, medical and healthcare management, and in the field of research, development, analysis and identification of processes to efficiently raise individual animals
N/A
N/A
No 97765170
No Service Mark
No 028581.0419
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
11th Nov 2024 | EXAMINERS AMENDMENT E-MAILED |
11th Nov 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
11th Nov 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
11th Nov 2024 | EXAMINERS AMENDMENT -WRITTEN |
11th Nov 2024 | EXAMINER'S AMENDMENT ENTERED |
05th Sep 2024 | FINAL REFUSAL WRITTEN |
05th Sep 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
05th Sep 2024 | FINAL REFUSAL E-MAILED |
18th Apr 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
18th Apr 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |